ABSTRACT
The notion that publicly funded research can be curiosity-driven, open-ended and detached from the realities of the present is under scrutiny in these times of austerity in the UK and the wider global economy. This chapter discusses the Technology Strategy Board (TSB) and how it operates within the UK innovation and research environment. It reviews one of its healthcare innovation platforms, as well as looking at a generalised model for increasing commercial output from co-operative research and development (CR&D) projects funded by the TSB. The assisted living innovation platform (ALIP) forms the focus of this case study in relation to promoting commercialisation from project outcomes. The funding of healthcare innovation and technology development immediately creates a challenge to the pure commercialisation goals of the TSB and publicly funded CR&D generally. The platform aims to support UK businesses and the health and care sector to develop innovative, cost-effective, user-centred technology and services for independent living.
